Literature DB >> 19093181

Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer.

Junji Akagi1, Hideo Baba.   

Abstract

BACKGROUND: Natural killer (NK)-like T cells comprising CD56(+) T cells and CD57(+) T cells belong to a subset of CD1d-independent NKT cells playing an important role in regulating immune responses. Although NK-like T cells are reported to increase in patients with advanced gastric carcinomas, it remains unknown how NK-like T cells are involved in disease progression in gastric cancer patients.
METHODS: The proportions of Th1 cells (interferon [IFN]-gamma-producing CD4(+) T cells), Th2 cells (IL-4-producing CD4(+) T cells), and NK-like T cells (CD56(+) T cells and CD57(+) T cells) in the peripheral blood of 48 gastric cancer patients and 20 healthy controls were measured by two-color flow cytometry analysis and by intracellular cytokine analysis to investigate an association of these immune cells with the survival rate of gastric cancer patients.
RESULTS: Univariate analysis showed that Th1 cells and CD57(+) T cells, as well as some clinicopathological factors, significantly influenced the survival rate. CD57-high (> or ==18%) patients survived for a significantly shorter period after surgery compared to CD57-low patients (P = 0.046; Kaplan-Meier, log-rank test) in the stage III-IV patients, but not in the stage I-II patients. Further, multivariate analysis showed that lymphatic invasion was a statistically significant independent risk factor in all the gastric cancer patients, but the proportion of CD57(+) T cells as well as depth of tumor were statistically significant independent risk factors in patients with advanced carcinomas (stage III-IV).
CONCLUSION: An increased proportion (> or ==18%) of CD57(+) T cells in the peripheral blood of patients with advanced gastric carcinomas could indicate a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19093181     DOI: 10.1007/s10147-008-0789-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  51 in total

1.  CD3+ CD57+ lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients.

Authors:  B Reipert; C Scheuch; A Lukowsky; P Reinke; E Fietze; W D Döcke; G Staffa; S Czerlinksi; R Hetzer; H D Volk
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation.

Authors:  E Leroy; C F Calvo; M Divine; M F Gourdin; F Baujean; M H Ben Aribia; Z Mishal; J P Vernant; J P Farcet; A Senik
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

3.  Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2.

Authors:  M Satoh; S Seki; W Hashimoto; K Ogasawara; T Kobayashi; K Kumagai; S Matsuno; K Takeda
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

4.  Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease.

Authors:  A Dupuy d'Angeac; S Monier; C Jorgensen; Q Gao; A Travaglio-Encinoza; C Bologna; B Combe; J Sany; T Rème
Journal:  Arthritis Rheum       Date:  1993-05

5.  Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma.

Authors:  S Koyama; T Ebihara; K Fukao
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer.

Authors:  T Okada; T Iiai; Y Kawachi; T Moroda; Y Takii; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection.

Authors:  E Legac; B Autran; H Merle-Beral; C Katlama; P Debre
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

8.  NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion.

Authors:  H Arase; N Arase; K Nakagawa; R A Good; K Onoé
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

9.  Increase in the proportion of granulated CD56+ T cells in patients with malignancy.

Authors:  Y Takii; S Hashimoto; T Iiai; H Watanabe; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.

Authors:  H Arase; N Arase; T Saito
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  19 in total

1.  Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.

Authors:  Richard C Wu; Shujuan Liu; Jessica A Chacon; Sheng Wu; Yufeng Li; Pariya Sukhumalchandra; James L Murray; Jeffrey J Molldrem; Patrick Hwu; Hanspeter Pircher; Gregory Lizée; Laszlo G Radvanyi
Journal:  Clin Cancer Res       Date:  2012-02-03       Impact factor: 12.531

2.  CD57 ratio as a convenient and useful immunological and prognostic parameter for stage IV carcinoma.

Authors:  Junji Akagi; Hideo Baba
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

3.  Terminally differentiated CD8+ T cells and CD57-FOXP3+CD8+ T cells are highly associated with the efficacy of immunotherapy using activated autologous lymphocytes.

Authors:  Junji Akagi; Hideo Baba; Teruaki Sekine; Kenji Ogawa
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

Review 4.  Inflammation-related factors predicting prognosis of gastric cancer.

Authors:  Wen-Jun Chang; Yan Du; Xin Zhao; Li-Ye Ma; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients.

Authors:  Junji Akagi; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2010-03-13       Impact factor: 3.402

6.  Malignant peripheral nerve sheath tumor (MPNST) in the spine: a retrospective analysis of clinical and molecular prognostic factors.

Authors:  Ting Wang; Huabin Yin; Shuai Han; Xinhai Yang; Jing Wang; Quan Huang; Wangjun Yan; Wang Zhou; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-01-20       Impact factor: 4.130

7.  CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.

Authors:  Matthew J Bottomley; Paul N Harden; Kathryn J Wood
Journal:  J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 10.121

8.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

Review 9.  Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.

Authors:  Carolyn M Nielsen; Matthew J White; Martin R Goodier; Eleanor M Riley
Journal:  Front Immunol       Date:  2013-12-09       Impact factor: 7.561

10.  Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer.

Authors:  Kai Liu; Kun Yang; Bin Wu; HaiNing Chen; XiaoLong Chen; XinZu Chen; LiLi Jiang; FuXiang Ye; Du He; ZhengHao Lu; Lian Xue; WeiHan Zhang; Qiu Li; ZongGuang Zhou; XianMing Mo; JianKun Hu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.